A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...

Sienna Eye Care will provide personalized solutions for eye conditions such as dry eyes, glaucoma, macular pediatric degeneration and diabetic retinopathy. It also will provide pediatric evaluations ...

A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...

Motorists risk being hit with an eye-watering £1,000 fine if they fail to declare certain conditions to the DVLA ...

Researchers have conducted one of the largest eye studies ever, revealing that retinal thickness could play a key role in ...

Motorists across the country could be at risk of a £1,000 fine if they fail to tell the DVLA about certain eye conditions.

AI-powered research on one of the largest eye studies to date has created the most detailed maps of the retina ever produced.

Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...

EyePoint Pharmaceuticals, Inc.’s EYPT share price has dipped by 15.13%, which has investors questioning if this is right time to buy.

The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.

A small percentage have had vision problems, but a direct causal link with the drugs has not been established.